{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:27:42Z","timestamp":1790267262629,"version":"4.1.0"},"reference-count":27,"publisher":"Wiley","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Xinjiang Key Laboratory of Neurological Disorder Research","award":["XJDX1711-2216"],"award-info":[{"award-number":["XJDX1711-2216"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parkinson's Disease"],"published-print":{"date-parts":[[2023,6,1]]},"abstract":"<jats:p>Background. Transcranial sonography (TCS) is a noninvasive test that can reveal structural changes in the substantia nigra (SN) in Parkinson\u2019s disease (PD). The purpose of this study was to investigate the relationship between SN signatures and clinical features in PD patients in a multiethnic region of China. Methods. A total of 147 patients with PD were included in the study, and all of whom had underwent a TCS examination. Clinical information was collected from PD patients, and motor and nonmotor symptoms were assessed using assessment scales. Results. There were differences in the substantia nigra hyperechogenicity (SNH) area between age of onset, visual hallucinations (VH), and UPDRS3.0 II scores (<jats:inline-formula>\n                     <a:math xmlns:a=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M1\">\n                        <a:mi>P<\/a:mi>\n                     <\/a:math>\n                  <\/jats:inline-formula>\u2009&lt;\u20090.05), patients with late onset PD had a greater SNH area than early onset (0.326\u2009\u00b1\u20090.352 vs. 0.171\u2009\u00b1\u20090.194), and PD patients presenting with VH had a greater SNH area than those without hallucinations (0.508\u2009\u00b1\u20090.670 vs. 0.278\u2009\u00b1\u20090.659), and further multifactorial analysis showed that a high SNH area was an independent risk factor for development of VH. The area under the ROC curve for predicting VH from the SNH area in PD patients was 0.609 (95% CI: 0.444\u20130.774). There was a positive correlation between the SNH area and UPDRS3.0-II scores, but further multifactorial analysis showed that SNH was not an independent predictor of the UPDRS3.0-II score. Conclusion. A high SNH area is an independent risk factor for development of VH, there is a positive correlation between the SNH area and UPDRS3.0 II score, and TCS has guiding significance in predicting clinical VH symptoms and activities of daily living in PD patients.<\/jats:p>","DOI":"10.1155\/2023\/8867546","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T03:55:15Z","timestamp":1685678115000},"page":"1-7","source":"Crossref","is-referenced-by-count":3,"title":["Substantia Nigra Echogenicity Signal Correlated with Clinical Features in Patients with Parkinson\u2019s Disease in Xinjiang"],"prefix":"10.1155","volume":"2023","author":[{"given":"Rurui","family":"Wei","sequence":"first","affiliation":[{"name":"The Second Affiliated Hospital of Xinjiang Medical University, Neuroencephalology Clinical Treatment Centre, Xinjiang Key Laboratory of Neurological Disorder Research, Urumqi, Xinjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Health Statistics, College of Public Health, Xinjiang Medical University, Urumqi, Xinjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peishan","family":"Li","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Xinjiang Medical University, Neuroencephalology Clinical Treatment Centre, Xinjiang Key Laboratory of Neurological Disorder Research, Urumqi, Xinjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeheng","family":"Xu","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Xinjiang Medical University, Neuroencephalology Clinical Treatment Centre, Xinjiang Key Laboratory of Neurological Disorder Research, Urumqi, Xinjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"La","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Xinjiang Medical University, Neuroencephalology Clinical Treatment Centre, Xinjiang Key Laboratory of Neurological Disorder Research, Urumqi, Xinjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"He","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Xinjiang Medical University, Neuroencephalology Clinical Treatment Centre, Xinjiang Key Laboratory of Neurological Disorder Research, Urumqi, Xinjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinfen","family":"Wu","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Xinjiang Medical University, Neuroencephalology Clinical Treatment Centre, Xinjiang Key Laboratory of Neurological Disorder Research, Urumqi, Xinjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youcai","family":"Shi","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Xinjiang Medical University, Neuroencephalology Clinical Treatment Centre, Xinjiang Key Laboratory of Neurological Disorder Research, Urumqi, Xinjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yuan","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Xinjiang Medical University, Neuroencephalology Clinical Treatment Centre, Xinjiang Key Laboratory of Neurological Disorder Research, Urumqi, Xinjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4592-0519","authenticated-orcid":true,"given":"Abudula","family":"Aisha","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Xinjiang Medical University, Neuroencephalology Clinical Treatment Centre, Xinjiang Key Laboratory of Neurological Disorder Research, Urumqi, Xinjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(09)60492-x"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.45.1.182"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2016.10.043"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2016.01.021"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2014.01.015"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.7863\/jum.2010.29.1.37"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21628"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(05)70285-4"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000004058"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.46.0271"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10473"},{"issue":"1","key":"12","article-title":"Guideline for primary care of Parkinson\u2019s disease (2019)","volume":"19","author":"D. Grimes","year":"2020","journal-title":"Chin J Gen Pract"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1096-8644(199907)109:3<303::aid-ajpa3>3.0.co;2-i"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07835-z"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2018.09.018"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-010-0504-6"},{"key":"17","volume-title":"The Analysis of Clinical Characteristics and Related Factors of Transcranial Sonography Substantia Nigra Hyperecho on Patients with Parkinson's Disease","author":"C. A. O. Xian","year":"2014"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1155\/1997\/230760"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.4.733"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-017-3155-7"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.70.6.727"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-010-0504-6"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-019-04110-z"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.33.11.1518"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.149.12.1701"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.144.6.662"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22335"}],"container-title":["Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/pd\/2023\/8867546.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/pd\/2023\/8867546.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/pd\/2023\/8867546.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T03:55:21Z","timestamp":1685678121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/pd\/2023\/8867546\/"}},"subtitle":[],"editor":[{"given":"Carlo","family":"Colosimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,6,1]]},"references-count":27,"alternative-id":["8867546","8867546"],"URL":"https:\/\/doi.org\/10.1155\/2023\/8867546","relation":{},"ISSN":["2042-0080","2090-8083"],"issn-type":[{"value":"2042-0080","type":"electronic"},{"value":"2090-8083","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,1]]}}}